A Review of Therapies for <i>Clostridioides difficile</i> Infection
<i>Clostridioides difficile</i> is an urgent public health threat that affects approximately half a million patients annually in the United States. Despite concerted efforts aimed at the prevention of <i>Clostridioides difficile</i> infection (CDI), it remains a leading cause...
Saved in:
| Main Authors: | Faiza Morado, Neha Nanda |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-12-01
|
| Series: | Antibiotics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2079-6382/14/1/17 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Gut microbiota differs between treatment outcomes early after fecal microbiota transplantation against recurrent Clostridioides difficile infection
by: Shaodong Wei, et al.
Published: (2022-12-01) -
The Efficacy of Fecal Microbiota Transplantation in Mouse Models Infected with <i>Clostridioides difficile</i> from the Perspective of Metabolic Profiling: A Systematic Review
by: Anna Voziki, et al.
Published: (2024-12-01) -
Extraintestinal Manifestations of <i>Clostridioides difficile</i> Infections: An Overview
by: Konstantinos Mpakogiannis, et al.
Published: (2025-07-01) -
Evaluation of the Efficacy of UV-C Radiation in Eliminating <i>Clostridioides difficile</i> from Touch Surfaces Under Laboratory Conditions
by: Anna Różańska, et al.
Published: (2025-04-01) -
Evaluating Bezlotoxumab-Fidaxomicin Combination Therapy in Clostridioides Infection: A Single-Center Retrospective Study from Aichi Prefecture, Japan
by: Jun Hirai, et al.
Published: (2025-02-01)